Talk Neuro to Me

GyroStim is the world’s only FDA-designated Breakthrough Device for rotational vestibular rehabilitation—a title earned through innovation, evidence, and unmatched results. Other motorized chairs may mimic the appearance, but none match the function, regulatory standing, or clinical effectiveness of GyroStim. As vestibular rehabilitation evolves, GyroStim leads the way—offering unmatched hope and healing for patients worldwide.

Dr. Jalili shares insights on brain health and the development of CereFLEX AM/PM, a Health-Canada-approved supplement designed to support cognitive function and memory. After more than 11 years of research and formulation, this neuro-metabolically focused approach combines antioxidants, amino acids, vitamins, minerals, and herbal remedies to aid those experiencing post-concussive challenges. Proudly formulated and manufactured in North America. Learn more: www.cereflexlabs.com For clinic orders (wholesale): https://cereflexlabs.com/pages/wholesale_registration For individual orders: https://cereflexlabs.com/products/am-pm-brain-supplement-package To make future podcast suggestions, visit https://CarrickInstitute.com

Dr. Shidlofsky shares his expertise on visual snow with us and walks us through his published paper titled "The efficacy of neuro-optometric visual rehabilitation therapy in patients with visual snow syndrome". The efficacy of neuro-optometric visual rehabilitation therapy in patients with visual snow syndrome: https://doi.org/10.3389/fneur.2022.999336 Neuro-Vision Associates of North Texas: https://www.dr-s.net/ To make future podcast suggestions, visit https://CarrickInstitute.com

Dr. Kalapp shares three strategies to grow your clinic. Dr. Kalapp has become a resource for clinicians looking to remove barriers and grow their businesses. The Kalapp Method: https://thekalappmethod.com/ To make future podcast suggestions, visit https://CarrickInstitute.com

In this Talk Neuro to Me episode, we interview Dallin Hardy, who shares with us the results of the NUTRIMUM study, which looked at alternative solutions for antenatal depression, which affects approximately 10% of women during pregnancy. Link to NUTRIMUM paper: https://www.cambridge.org/core/journals/bjpsych-open/article/efficacy-and-safety-of-a-mineral-and-vitamin-treatment-on-symptoms-of-antenatal-depression-12week-fully-blinded-randomised-placebocontrolled-trial-nutrimum/84BC34CD9F2689AE9D790F69B5D7C673 To make future podcast suggestions, visit: CarrickInstitute.com